Orna Therapeutics
Hope D'Oyley-Gay currently serves as the Chief Legal Officer and Corporate Secretary at Orna Therapeutics, a role assumed in September 2023. Prior to this position, D'Oyley-Gay held the title of General Counsel and Corporate Secretary at AGTC from 2021 to 2022, and General Counsel, Corporate Secretary, and Vice President of Administration at Spirovant Sciences, Inc. from 2019 to 2021. D'Oyley-Gay's legal career includes serving as Counsel at Reed Smith LLP in the Life Sciences Transaction Team and in various roles including Vice President and Associate General Counsel at GlaxoSmithKline. Additionally, D'Oyley-Gay has extensive experience in health law, having worked at boutique firms and as an Associate Judicial Law Clerk. Academic credentials include a Doctor of Law (J.D.) from the University of Pennsylvania Carey Law School and a Bachelor of Science (B.S.) in Economics from the University of Delaware.
This person is not in any teams
This person is not in any offices
Orna Therapeutics
1 followers
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way it treats disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions.